scholarly article | Q13442814 |
P50 | author | Susan Buchbinder | Q7647625 |
Eric Vittinghoff | Q37323613 | ||
Patrick S. Sullivan | Q39915183 | ||
K Rivet Amico | Q58238816 | ||
Nancy Hessol | Q91058762 | ||
P2093 | author name string | Risha Irvin | |
Albert Y Liu | |||
Jonathan Fuchs | |||
Travis Sanchez | |||
R Craig Sineath | |||
Elizabeth Kroboth | |||
P2860 | cites work | Estimated HIV incidence in the United States, 2006-2009 | Q21135528 |
Interventions for enhancing medication adherence | Q24243296 | ||
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men | Q24612082 | ||
Preexposure prophylaxis for HIV prevention: where have we been and where are we going? | Q26825042 | ||
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women | Q28270788 | ||
Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial | Q28292876 | ||
Preexposure prophylaxis for HIV infection among African women | Q29620077 | ||
Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana | Q29620078 | ||
Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis | Q30539620 | ||
The acceptability and feasibility of an HIV preexposure prophylaxis (PrEP) trial with young men who have sex with men. | Q30539886 | ||
Patient-related risks for nonadherence to antiretroviral therapy among HIV-infected youth in the United States: a study of prevalence and interactions | Q33797229 | ||
State of the science of adherence in pre-exposure prophylaxis and microbicide trials | Q33798685 | ||
Long-term patient adherence to antiretroviral therapy | Q33946511 | ||
Sexual frequency and planning among at-risk men who have sex with men in the United States: implications for event-based intermittent pre-exposure prophylaxis | Q36188256 | ||
Use of and Adherence to Antiretroviral Therapy in a Large U.S. Sample of HIV-infected Adults in Care, 2007-2008. | Q36302253 | ||
From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. | Q36760768 | ||
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women | Q36839544 | ||
Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials | Q36902453 | ||
Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. | Q37042094 | ||
Participant experiences and facilitators and barriers to pill use among men who have sex with men in the iPrEx pre-exposure prophylaxis trial in San Francisco | Q37216377 | ||
Pharmacologic issues in management of chronic disease | Q38011470 | ||
Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness | Q38042297 | ||
Early patterns of adherence in adolescents initiating highly active antiretroviral therapy predict long-term adherence, virologic, and immunologic control | Q42880140 | ||
Optimal recall period and response task for self-reported HIV medication adherence | Q43753135 | ||
Vital signs: HIV testing and diagnosis among adults--United States, 2001-2009. | Q43855928 | ||
Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus | Q45428923 | ||
Becoming adherent: experiences of persons living with HIV/AIDS. | Q48440005 | ||
Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. | Q51157878 | ||
The eldest of older adults living with HIV: response and adherence to highly active antiretroviral therapy | Q81823514 | ||
P433 | issue | 12 | |
P921 | main subject | men who have sex with men | Q853451 |
United States of America | Q30 | ||
P304 | page(s) | 622-627 | |
P577 | publication date | 2014-12-01 | |
P1433 | published in | AIDS Patient Care and STDs | Q15746602 |
P1476 | title | Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation | |
P478 | volume | 28 |
Q36343061 | 2015 - a seminal year for HIV biomedical prevention |
Q35857364 | Attitudes Towards PrEP and Anticipated Condom Use Among Concordant HIV-Negative and HIV-Discordant Male Couples |
Q48113555 | Expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in New South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation trial |
Q46535667 | Facilitators and Barriers to Pre-Exposure Prophylaxis Willingness Among Young Men Who Have Sex with Men Who Use Geosocial Networking Applications in California |
Q38616485 | Factors Supporting and Hindering Adherence to Rectal Microbicide Gel Use with Receptive Anal Intercourse in a Phase 2 Trial |
Q91721667 | Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study |
Q47104527 | Improving the Adherence to Antiretroviral Therapy, a Difficult but Essential Task for a Successful HIV Treatment-Clinical Points of View and Practical Considerations |
Q39127005 | Markov Mixed Effects Modeling Using Electronic Adherence Monitoring Records Identifies Influential Covariates to HIV Preexposure Prophylaxis |
Q43122988 | Patient Experiences of Men Who Have Sex with Men Using Pre-Exposure Prophylaxis to Prevent HIV Infection. |
Q33908319 | Perceived Advantages and Disadvantages of Using Pre-Exposure Prophylaxis (PrEP) among Sexually Active Black Women: An Exploratory Study. |
Q40681760 | Pill Burden Influences the Association Between Time-Based Prospective Memory and Antiretroviral Therapy Adherence in Younger But Not Older HIV-Infected Adults |
Q58083051 | Pre-Exposure Prophylaxis Knowledge and Perceived Effectiveness to Prevent HIV Among Deaf Gay, Bisexual, and Queer Men |
Q59350498 | Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men |
Q60915851 | Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions |
Q37212913 | The current status of the use of oral medication to prevent HIV transmission |
Search more.